[慢性疾病药物服务与葡萄牙语背景的比较]
Margarida Castel-Branco1, Salomé Panta Baltazar2, Hélder Mota-Filipe3
1Laboratório de Farmacologia e Cuidados Farmacêuticos. Faculdade de Farmácia. Universidade de Coimbra. Coimbra. Portugal; Instituto de Investigação Clínica e Biomédica de Coimbra (iCBR). Coimbra. Portugal.
Acta medica portuguesa
|April 4, 2025
概括
社区药剂师是管理慢性病患者的关键. 这项研究比较了国际药物更新法律,为葡萄牙提出了一个优化的协议,以改善患者获得和医疗保健.
科学领域:
- 药房实践 在药房实践中
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 社区药剂师越来越多地融入慢性疾病管理,以减少医疗保健系统的负担.
- 药剂师拥有药物专业知识和临床技能,用于治疗坚持和在预约之间监测患者.
- 慢性病药物更新是药房的重要服务,以简化患者获得药物和持续医疗保健.
研究的目的:
- 审查和比较有关慢性药物更新服务的国际立法.
- 将这些服务与葡萄牙法律进行比较.
- 为葡萄牙的慢性药物更新服务提出一个优化的药房干预协议.
主要方法:
- 在不同国家 (英国,加拿大,爱尔兰,澳大利亚,美国) 的慢性药物更新服务的比较立法审查.
- 分析葡萄牙有关长期药物更新的法律.
- 拟议的药房干预协议的制定.
主要成果:
- 葡萄牙的服务与英国的重复处方有相似之处 (12个月处方,处方历史记录访问).
- 加拿大的"适应处方"更全面 (24个月处方,临床信息访问,处方者通知).
- 爱尔兰的处方延期是有限的;澳大利亚的持续发放和美国的紧急补充有很大的不同,不需要长期处方.
结论:
- 葡萄牙的慢性药物更新服务满足医疗保健系统的需求.
- 该服务在改善患者护理方面具有重大潜力,特别是在慢性疾病的治疗管理方面.
- 国际比较显示了葡萄牙服务协议的优化领域.
相关概念视频
01:15Methods of Documentation VI: Case Management Model
546
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
546
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
375
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
375
01:26COPD: Management Using Bronchodilators and Corticosteroids
152
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
152
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K